Latest News
We have some important companies with Palantir, Super Micro computer, Block, Moderna, Qualcomm, Arista Networks, Gilead Sciences and Airbnb all set to report.
Bristol Myers Squibb (BMY) Q3 2024 Earnings Call Transcript
BMY earnings call for the period ending September 30, 2024.
This article highlights a standout healthcare REIT that offers investors a strong 5% dividend yield.
These two growth stocks could be great additions to a long-term buy-and-hold portfolio.
After more than doubling in the past year, is this clinical-stage biotech stock still a buy?
Johnson & Johnson Beats Wall Street Estimates. Is It Time to Buy, Sell, or Hold?
Third-quarter results exceeded estimates, but the company also lowered overall earnings expectations for 2024.
2 Passive-Income Stocks to Load Up On in October
These two dividend powerhouses are ideal choices for passive-income investors.
Why Prime Medicine Stock Soared Nearly 12% Higher on Monday
Changes are afoot at the company, and investors welcomed them.
3 Surprisingly Underrated Stocks to Buy Right Now
These stocks might look like bad picks. But appearances can be deceiving.
The S&P 500 Index ($SPX ) (SPY ) Friday closed down by -0.13%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up by +0.33%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.53%. Stocks on Friday settled mixed, with the Dow Jones Industrials climbing...
The S&P 500 Index ($SPX ) (SPY ) today is down by +0.09%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up by +0.45%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -0.36%. Stocks today are mixed, with the Dow Jones Industrials climbing to...
The S&P 500 Index ($SPX ) (SPY ) today is up by +0.04%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up by +0.93%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -0.30%. Stocks today are mixed, with the Dow Jones Industrials climbing to...
FDA Approves Bristol Myers Squibb’s Schizophrenia Medication
The U.S. Food and Drug Administration (FDA) has approved pharmaceutical company Bristol Myers Squibb’s ...
Edgewise Therapeutics was a massive winner last week after positive results on its cardiovascular treatment. This there still room for the stock to run?
3 High-Yield Dividend Stocks Down by More Than 39% to Buy Now and Hold at Least a Decade
Now could be a great time to scoop up three stocks trading way below their previous peaks.
Got $200? 2 Healthcare Stocks to Buy and Hold Forever
These two stocks have had their issues in recent years, but both look like reliable long-term bets.
Zenas is a Bristol Meyers Squibb-backed pharma company that is about to go public. Its treatment provides solid differentiation that could rival competitors.
2 Unstoppable Dividend Growth Stocks You Can Buy Now With $100
These dividend payers could more than double their payouts in the decade ahead.
A strong pipeline of products could potentially transform these companies, but there are risks.
2 Reasons Bristol Myers Squibb Stock Could Be a Bargain, Down 34% From Its All-Time High
Rebounding growth could make shares of this leading drugmaker a big winner.
2 No-Brainer Large-Cap Stocks to Buy With $500 Right Now
No stock is perfect, but quality businesses can stand the test of time in your portfolio.
3 High-Yield Dividend Stocks With Payout Ratios Below 75%
Unlock steady income and growth potential with these high-yield, low-risk dividend powerhouses.
2 Beaten-Down S&P 500 Dividend Stocks to Buy on the Dip and Hold Forever
These underappreciated dividend payers offer yields above 4% at recent prices.
3 High-Yield Dividend Stocks You Can Buy With $200 Now and Hold at Least a Decade
With yields above 4%, these stocks could do a lot to boost your passive income stream
Where Will Bristol Myers Squibb Be in 5 Years?
The drugmaker will go through key changes by the end of the decade.